Showing results (101-110 of 155) with videos related to
Sort By:
Pageof 16
Psychopharmacology|March 30, 2007
Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in ratsAgnès L Auclair, Alexandra Galinier, Joël Besnard, et al.Oral Surgery, Oral Medicine, and Oral Pathology|September 1, 1989
Virus-associated dysplasia (bowenoid papulosis?) of the oral cavityF J Kratochvil, G A Cioffi, P L Auclair, et al.Clinical and Experimental Immunology|January 1, 1992
Immunization of mice with mycobacterial culture filtrate proteinsR D Hubbard, C M Flory, F M CollinsInfection and Immunity|March 1, 1983
Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasisJ O Hill, R J North, F M CollinsJournal of General Microbiology|June 1, 1982
Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazonesF M Collins, D L Klayman, N E MorrisonInternational Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|December 1, 1983
Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigensF M Collins, N E Morrison, S R WatsonCellular Immunology|October 15, 1984
Acquired immunity to heavy infection with Mycobacterium bovis bacillus Calmette-Guérin and its relationship to the development of nonspecific unresponsiveness in vitroI M Orme, M J Ratcliffe, F M CollinsInfection and Immunity|October 1, 1986
Genetic control of natural resistance to nontuberculous mycobacterial infections in miceI M Orme, R W Stokes, F M CollinsNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2006
Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockadeAgnès L Auclair, Mark S Kleven, Joël Besnard, et al.BMC Cancer|September 22, 2009
Response to gefitinib and erlotinib in Non-small cell lung cancer: a restrospective studyIvette F Emery, Chiara Battelli, Paul L Auclair, et al.Pageof 16